A retrospective real-world analysis presented at the 2025 ASH Annual Meeting and Exposition showed that circulating tumor DNA (ctDNA) detected at the end of treatment (EOT) was a prognostic indicator ...

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

This article is all about what’s new and what it might mean for us, covering the latest in genetics in news. New methods like ...

A large Mayo Clinic study shows that current guidelines fail to detect nearly 90% of people with familial hypercholesterolemia, a common inherited cause of dangerously high cholesterol. Many affected ...

Cancer involves more than just genetic mutations; it also involves structural failures. Consider a city where roads disappear, isolating communities from vital resources.

The United States DNA polymerase market is projected to reach USD 246.9 million by 2035, supported by rising investments in ...

Tuberculosis (TB) is one of the oldest and deadliest infectious diseases we know. It commonly impacts the lungs, but can also affect other areas of the body like the spine, brain or kidneys.

Have you ever bitten into a supermarket tomato and wondered where all the flavor went? You're not imagining things. That ...

"Our mission is to detect colon cancer before it becomes life-threatening," said Dr. Wei-Wu He, Executive Chairman of Human Longevity. "Early detection isn't about relying on one test -- it's about ...

North America currently leads the DNA Synthesis Market due to its mature biotech ecosystem, heavy investment in genomics, and ...

Two University of Wisconsin researchers Edgar Spalding and Takeshi Yoshihara recently published a study concluding that there ...

A team from the Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER) has developed an innovative ...